Drug Type Small molecule drug  | 
Synonyms MK 3697  | 
Target  | 
Action antagonists  | 
Mechanism OX2R antagonists(Orexin receptor type 2 antagonists)  | 
Therapeutic Areas  | 
Active Indication-  | 
Inactive Indication  | 
Originator Organization  | 
Active Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhaseDiscontinuedPhase 2  | 
First Approval Date-  | 
Regulation-  | 
Molecular FormulaC23H21N5O3S  | 
InChIKeyVSOUDUXMPUHJEU-UHFFFAOYSA-N  | 
CAS Registry1224846-01-8  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Sleep Initiation and Maintenance Disorders | Phase 2 | United States   | - | |
| Sleep Wake Disorders | Phase 2 | - | - | 





